[go: up one dir, main page]

FR2095112A5 - - Google Patents

Info

Publication number
FR2095112A5
FR2095112A5 FR7120913A FR7120913A FR2095112A5 FR 2095112 A5 FR2095112 A5 FR 2095112A5 FR 7120913 A FR7120913 A FR 7120913A FR 7120913 A FR7120913 A FR 7120913A FR 2095112 A5 FR2095112 A5 FR 2095112A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7120913A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP45049666A priority Critical patent/JPS4817267B1/ja
Priority to US145468A priority patent/US3867437A/en
Priority to NL7107358A priority patent/NL7107358A/xx
Priority to SE07336/71A priority patent/SE366542B/xx
Priority to CH857671A priority patent/CH555806A/xx
Priority to DE2128381A priority patent/DE2128381C3/de
Priority to GB1949271*[A priority patent/GB1320484A/en
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Priority to FR7120913A priority patent/FR2095112A5/fr
Priority to BE768276A priority patent/BE768276A/fr
Application granted granted Critical
Publication of FR2095112A5 publication Critical patent/FR2095112A5/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C1/00—Ingredients generally applicable to manufacture of glasses, glazes, or vitreous enamels
    • C03C1/002—Use of waste materials, e.g. slags
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7120913A 1970-06-09 1971-06-09 Expired FR2095112A5 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP45049666A JPS4817267B1 (fr) 1970-06-09 1970-06-09
US145468A US3867437A (en) 1970-06-09 1971-05-20 N-acyl-N{40 -substituted-2,6-diamino-benzoic acids and process for making the same
NL7107358A NL7107358A (fr) 1970-06-09 1971-05-28
SE07336/71A SE366542B (fr) 1970-06-09 1971-06-07
CH857671A CH555806A (de) 1970-06-09 1971-06-08 Verfahren zur herstellung von derivaten der 2,6-diaminobenzoesaeure.
DE2128381A DE2128381C3 (de) 1970-06-09 1971-06-08 N-Acyl-N'-substituierte-a.e-Diaminobenzosäurederivate und Verfahren zu ihrer Herstellung
GB1949271*[A GB1320484A (en) 1970-06-09 1971-06-08 2,6-diaminobenzoic acid derivatives
FR7120913A FR2095112A5 (fr) 1970-06-09 1971-06-09
BE768276A BE768276A (fr) 1970-06-09 1971-06-09 Acides n-acyl-n'-substitue-2,6-diaminobenzoiques et leur preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP45049666A JPS4817267B1 (fr) 1970-06-09 1970-06-09
FR7120913A FR2095112A5 (fr) 1970-06-09 1971-06-09

Publications (1)

Publication Number Publication Date
FR2095112A5 true FR2095112A5 (fr) 1972-02-04

Family

ID=26216441

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7120913A Expired FR2095112A5 (fr) 1970-06-09 1971-06-09

Country Status (9)

Country Link
US (1) US3867437A (fr)
JP (1) JPS4817267B1 (fr)
BE (1) BE768276A (fr)
CH (1) CH555806A (fr)
DE (1) DE2128381C3 (fr)
FR (1) FR2095112A5 (fr)
GB (1) GB1320484A (fr)
NL (1) NL7107358A (fr)
SE (1) SE366542B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110071125A1 (en) * 2007-05-11 2011-03-24 Joachim Rudolph Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0660145B2 (ja) * 1989-02-09 1994-08-10 東洋紡績株式会社 新規置換アセトアミド化合物
US5183891A (en) * 1989-11-09 1993-02-02 Orsan Method for the preparation of substituted 1,4-dihydro-4-oxo-cinnoline-3-carboxylic acid, esters and salts thereof, and intermediates used in their preparation
AU2003258491A1 (en) * 2002-09-05 2004-03-29 Neurosearch A/S Amide derivatives and their use as chloride channel blockers
US20110039819A1 (en) * 2008-04-22 2011-02-17 Marion Hitchcock Substituted phenoxybenzamides
EP2491015A1 (fr) * 2009-10-21 2012-08-29 Bayer Pharma Aktiengesellschaft Benzosulfonamides substitués

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413313A (en) * 1964-06-18 1968-11-26 Parke Davis & Co Anthranilic acid compounds and methods for their production

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110071125A1 (en) * 2007-05-11 2011-03-24 Joachim Rudolph Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity

Also Published As

Publication number Publication date
NL7107358A (fr) 1971-12-13
DE2128381A1 (de) 1971-12-16
JPS4817267B1 (fr) 1973-05-28
US3867437A (en) 1975-02-18
SE366542B (fr) 1974-04-29
DE2128381B2 (de) 1979-04-05
DE2128381C3 (de) 1979-11-29
CH555806A (de) 1974-11-15
BE768276A (fr) 1971-11-03
GB1320484A (en) 1973-06-13

Similar Documents

Publication Publication Date Title
AR204384A1 (fr)
ATA96471A (fr)
FR2102170B2 (fr)
AU2044470A (fr)
AU1146470A (fr)
AU1473870A (fr)
AU2085370A (fr)
AU1336970A (fr)
AU2017870A (fr)
AU1833270A (fr)
AU1716970A (fr)
AU2130570A (fr)
AU1517670A (fr)
AU1326870A (fr)
AU1591370A (fr)
AU1841070A (fr)
AU1328670A (fr)
AU1343870A (fr)
AU1277070A (fr)
AU2144270A (fr)
AU2131570A (fr)
AU2130770A (fr)
AU1247570A (fr)
AU1581370A (fr)
AU1235770A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse